Updates - -
NHS Discharge Medicines Service launched
The NHS Discharge Medicines Service (DMS) launched yesterday (Monday 15 February) and is available in all community pharmacies in England
NHS Community Pharmacist Consultation Service (CPCS) Survey
We would like to assess the current levels of interest, capacity and readiness for the Community Pharmacy Consultation Service programme.
Covid-19 Vaccine: MHRA precautionary advice on allergies issued
MHRA has issued the following advice to healthcare professionals
Suspension of the need for signatures on prescriptions, dental and ophthalmic forms
The Secretary of State for Health and Social Care has approved a temporary measure in England to help limit the transmission of coronavirus (COVID-19) by suspending the need for patients to sign prescription, dental and ophthalmic forms for a period of 5 months to 31 March 2021.
Thank you to pharmacy technicians
Chief pharmaceutical officer (CPhO) Dr Keith Ridge has written an open letter to all pharmacy technicians, published on the Association of Pharmacy Technicians UK website, to thank them for their incredible contribution to and support for excellent patient care throughout the COVID-19 pandemic so far.
GP Referral to Community Pharmacist Consultation Service to be made available across England
GP practices across England will be able to refer patients with minor illnesses asking for a GP appointment for a same day consultation with a community pharmacist, as part of a new referral pathway to the NHS Community Pharmacist Consultation Service (CPCS)
Updated End of Life medication Access Database for NEL
The latest information on access to end of life medicines in north east London
Roll out of Electronic Prescription Service (EPS) Phase 4
To help you prepare for winter, NHS England is accelerating deployment of EPS Phase 4 which allows EPS to be used for patients without a pharmacy nomination. All GP practices using EPS with TPP SystmOne and EMIS Web will be live with Phase 4 by mid-September.
Rapid evidence summary: vitamin D for COVID-19
This evidence summary sets out the best available evidence on vitamin D for preventing or treating COVID-19, or for the susceptibility to COVID-19 based on vitamin D status
Medicines Supply Notification for Flixotide nebules
Flixotide® 0.5mg/2ml and 2mg/2ml nebules are out of stock from late June and August 2020, respectively
Dexamethasone in COVID-19
The RECOVERY trial in COVID-19 has provided initial results of the dexamethasone arm
Temporary changes to the need for patient consent for eRD
This letter is to formally notify you of temporary changes to the need for patient consent (using the powers granted by the National Health Service (Amendments Relating to the Provision of Primary Care Services During a Pandemic etc.) Regulations 2020 during the COVID-19 response) to maximise use of the electronic repeat dispensing (eRD) system.